The India Cements (INDIACEM) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
1 Sep, 2025Executive summary
Unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2024 were reviewed and approved by the Board on 21 January 2025.
The company became a subsidiary of UltraTech Cement Ltd as of 24 December 2024, with UltraTech's shareholding rising to 55.49%.
Financial highlights
Standalone revenue from operations for Q3 FY25 was ₹903.16 crore, down from ₹1,081.88 crore in Q3 FY24; nine-month revenue was ₹2,891.34 crore versus ₹3,697.05 crore year-over-year.
Standalone net loss for Q3 FY25 was ₹428.84 crore, compared to a net loss of ₹16.51 crore in Q3 FY24; nine-month net loss was ₹591.90 crore versus ₹173.19 crore year-over-year.
Consolidated revenue from operations for Q3 FY25 was ₹940.81 crore, down from ₹1,113.06 crore in Q3 FY24; nine-month consolidated revenue was ₹2,951.48 crore versus ₹3,762.11 crore year-over-year.
Consolidated net profit for Q3 FY25 was ₹122.30 crore, compared to a net loss of ₹0.67 crore in Q3 FY24; nine-month consolidated net loss was ₹158.36 crore versus ₹166.79 crore year-over-year.
Outlook and guidance
The company is focused on restructuring and asset sales, including the planned divestment of two subsidiaries, to improve financial health.
Latest events from The India Cements
- Q1 FY27 delivered double-digit volume growth, record EBITDA, and stable financial health.INDIACEM
Q1 26/2720 Jul 2026 - Sales and margins improved, with restructuring and expansion amid ongoing legal risks.INDIACEM
Q2 25/269 Jul 2026 - Double-digit volume growth targeted for FY26, with improved margins and narrowed losses.INDIACEM
Q1 25/268 Jul 2026 - Record capacity, robust growth, higher dividends, and restructuring amid legal and cost headwinds.INDIACEM
Q4 25/2628 Apr 2026 - Sales up 25% YoY, revenue higher, but net losses persist amid cost and legal risks.INDIACEM
Q3 25/2613 Apr 2026 - Profitability returned in Q1 FY25 on an exceptional gain, with major stake sale to UltraTech Cement.INDIACEM
Q1 24/251 Sep 2025 - Losses widened on lower revenue, with major asset sales and a pending UltraTech acquisition.INDIACEM
Q2 24/251 Sep 2025 - FY25 saw deeper losses, lower revenue, and major legal disputes, with auditors' unmodified opinions.INDIACEM
Q4 24/251 Sep 2025